AEON Biopharma Inc.

NASDAQ: AEON · Real-Time Price · USD
0.80
0.02 (2.56%)
At close: Aug 15, 2025, 3:59 PM
0.80
-0.62%
After-hours: Aug 15, 2025, 07:50 PM EDT

AEON Biopharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
13K 5.16M 9.75M 5.13M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
29K 29K 34K 360K
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
1.58M 1.06M 92K 26K
Total Current Assets
1.59M 6.22M 9.84M 5.15M
Property-Plant & Equipment
1.52M 594K 906K 922K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
1.55M 623K 940K 1.28M
Total Assets
3.14M 6.84M 10.78M 6.44M
Account Payables
5.91M 3.39M 7.8M 1.19M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a n/a 70.87M 15.6M
Other Current Liabilities
1.07M 943K 1.11M 1.07M
Total Current Liabilities
14.15M 13.05M 82.57M 20.8M
Long-Term Debt
11.69M n/a 60.43M 70.76M
Other Long-Term Liabilities
4.73M 146.84M 137.95M 138.17M
Total Long-Term Liabilities
17.56M 146.84M 198.62M 209.46M
Total Liabilities
31.71M 159.89M 281.19M 230.26M
Total Debt
12.96M 278K 131.53M 86.89M
Common Stock
4K 4K 14K 14K
Retained Earnings
-431.6M -473.6M -474.84M -422.28M
Comprehensive Income
n/a n/a n/a n/a
Shareholders Equity
-28.57M -153.04M -287.5M -234.94M
Total Investments
n/a n/a n/a n/a